Table 2.
Subject information.
| Subject | Trial order | Gender | Dominant leg | Baseline gait velocity (m/s) | Baseline step length asymmetry (%) | Baseline step time asymmetry (%) |
|---|---|---|---|---|---|---|
| S-3 | III | M | L | 1.15 | 2.4 | 5.2 |
| S-4 | IV | M | R | 1.15 | 2.5 | 2.1 |
| S-6 | VI | M | R | 1.10 | −0.5 | −2.9 |
| S-8 | II | F | R | 1.00 | −1.1 | 4.7 |
| S-9 | III | F | R | 1.00 | −2.3 | −1.8 |
| S-10 | IV | M | R | 1.17 | −1.4 | 2.0 |
| S-11* | V | F | R | 1.10 | 3.3 | −3.8 |
| S-13 | I | M | R | 1.20 | −5.0 | −2 |
| S-14 | V | F | L | 1.15 | 1.2 | 2.6 |
| S-15 | VI | F | L | 1.00 | 1.1 | −1.6 |
| S-16 | I | M | R | 1.10 | 1.1 | 0.9 |
The table outlines the eleven eligible subjects’ assigned randomized trial order, dominant leg, step length asymmetry (0.12 ± 2.45%), and step time asymmetry (0.49 ± 3.08%) at baseline conditions on the day of initial eligibility assessment. A negative asymmetry indicates that the gait parameter was relatively greater in magnitude on the right limb.
*
Subject 11 was not included in the study due to a very high baseline during trial 5.